TSLA Deep Dive: What Retail Investors See That Institutions Still Won’t Price
The Tesla bull case has never been about cars. Institutions know this — and they’re still not pricing it in. Here’s a clear-eyed look at the five theses, the real risks, and why retail conviction might actually be ahead of the smart money.
The Base Case: Model Y Headwinds and Why They’re Not the Story
Let’s start with what’s actually happening at the core business.
Tesla’s Model Y — the world’s best-selling vehicle — is facing genuine headwinds in 2026. Intensified competition from Chinese EV manufacturers (BYD, SAIC, Li Auto) has compressed market share in China, Tesla’s second-largest market. In the US and Europe, softening EV adoption growth rates and a return of legacy manufacturers to the segment have slowed the easy-win phase of the EV rollout. In Q1 this year, Tesla delivered 358,023 vehicles — strong production of 408,000+ units, but modest YoY growth against a challenging macro backdrop.
The bears look at these numbers and declare the Tesla story over. They’re analysing the wrong company.
Tesla has been transitioning — deliberately, with Musk stating it explicitly on the Q1 2026 earnings call — from a car company to an autonomous transport and energy infrastructure company. The vehicles are the training data platform. If execution succeeds, the margins will inevitably come from software and energy.
Valuation: Why the P/E is Misleading
As of market close, Friday May 22, 2026, the current TSLA metrics:
- Share price: $426.01 (+1.95% on the day)
- Market cap: $1.60 trillion
- Trailing P/E (TTM): 390.83
- Forward P/E: 204.08
The instinctive response to TSLA’s valuation is sticker shock — the P/E ratio makes it look expensive relative to any traditional automotive benchmark. But that’s the wrong benchmark. Compare it instead to:
- A technology platform company: if FSD (Full Self-Driving) reaches full autonomy, Tesla owns the software layer on every vehicle it has ever sold — a perpetual licence fee embedded in 5+ million cars already on the road
- A robotics company: if Optimus deploys at scale, the addressable market is every form of physical labour
- An energy company: Tesla Energy (Megapack) is already generating real revenue with high-margin utility-scale deployments
The market is applying a blended multiple that tries to account for all of this while hedging against the risk that none of it materialises. That ambiguity is exactly where retail investors are willing to hold conviction differently than institutional fund managers who have quarterly benchmarks to meet.
The Five Tesla Theses
Thesis 1: EV — The Business That Pays the Bills
Despite the headwinds, Tesla’s core EV business remains cash-generative and structurally advantaged. Its manufacturing efficiency — measured by cost per vehicle — is still well ahead of legacy manufacturers. The Cybercab, designed for high volume at lower cost than any current Tesla model, is intended to eventually become the primary product line.
Musk stated on the Q1 2026 earnings call: “90% of miles driven are with one or two people. You’d want a vast majority of your production to be Cybercab over time.”
The EV thesis isn’t dead. It’s transforming.
Thesis 2: FSD and the Autonomous Robotaxi Network
This is the thesis retail investors believe most fervently — and institutions have been most resistant to underwrite.
What’s confirmed:
- Cybercab production started at Gigafactory Texas, confirmed April 23, 2026
- First production unit rolled off the line in February 2026
- Self-certified against all Federal Motor Vehicle Safety Standards — no NHTSA cap applies (confirmed by VP Lars Moravy)
- Production ramp currently “very slow,” with Musk describing an S-curve heading “exponential towards end of year”
- Unsupervised FSD not yet available commercially — Musk targeted “probably Q4 2026” on the earnings call
- Tesla’s internally published supervised-FSD safety data reports lower crash frequency under certain operating conditions than US averages (though critics dispute the comparability of those benchmarks)
The competition:
Waymo (Alphabet subsidiary) is the most credible competitor. It operates commercially deployed robotaxi fleets in Phoenix, San Francisco, Los Angeles, and Austin, using a lidar + camera + HD map approach — more expensive per vehicle but more proven in unsupervised deployment. Waymo is years ahead of Tesla on unsupervised autonomy but lacks Tesla’s scale advantage for training data. Cruise (GM) suffered setbacks after a 2023 incident and is still rebuilding. Chinese players — Baidu Apollo, Didi, WeRide — are operational domestically but carry limited Western market presence.
The retail bull case on FSD: Tesla’s real-world fleet data flywheel creates a compounding advantage. The more miles the supervised fleet drives, the better the model trains, the faster unsupervised capability is reached. And when it arrives, Tesla can deploy it across existing vehicles via OTA update — unlocking a new revenue stream from 5+ million already-sold cars, effectively overnight.
The institutional sceptic case: Musk has been promising this since 2019. Timeline slippage has been severe and consistent. The supervised crash rate is still roughly 4x the human benchmark. Until unsupervised FSD is live and performing safely at commercial scale, it remains a promise, not a balance sheet asset.
The autonomous trucking angle:
Tesla Semi deliveries began in December 2022 at PepsiCo’s California facility. The Q1 2026 Shareholder Update (April 22, 2026) confirmed the Semi was in pilot production at the Nevada facility, with volume production of both Cybercab and Tesla Semi expected this year. Gigafactory Nevada is designed for an eventual ~50,000 Semi units per year at full capacity. The first Semi rolled off the new high-volume production line at the dedicated ~1.7 million sq ft factory in April.
Thesis 3: Megapack — Energy on Demand
This is the most underrated Tesla thesis and the one that most clearly justifies a premium over pure automotive peers.
Tesla Energy — Megapack utility-scale battery storage and Powerwall home batteries — has been one of the fastest-growing segments. Each Megapack installation generates high-margin, recurring service revenue from major utilities and grid-scale projects. In some quarters of 2024, Energy generated revenue comparable to the automotive segment — a milestone that received minimal coverage relative to vehicle delivery numbers. Tesla still expects full-year 2026 energy deployments to exceed 2025, and Services & Other showed the strongest growth rate in Q1, underscoring a meaningful shift toward non-vehicle recurring revenue.
The thesis is structural: the global energy transition requires massive battery storage infrastructure, and Tesla holds a manufacturing cost advantage with an established product and a growing order book. This isn’t speculative — it’s already generating real money.
Thesis 4: Optimus — Cheap Labour at Scale
Optimus is the most speculative of the five theses and needs to be treated as such.
Tesla has demonstrated working Optimus prototypes, and Musk has made ambitious claims about volume production and eventual commercial deployment — a general-purpose humanoid robot capable of performing physical tasks currently requiring human labour, from assembly-line work to warehouse operations. The bull case is transformational: if Tesla can manufacture humanoid robots at automotive scale, the labour disruption dwarfs anything in the automotive or energy theses. Musk has suggested Optimus could eventually be worth more than all other Tesla businesses combined.
The reality check demands more than a footnote. As of May 2026, Optimus remains in early production and field-testing. No commercial deployment at meaningful scale has been confirmed. The competitive landscape is no longer a greenfield — Figure, Physical Intelligence, and Boston Dynamics are all advancing purpose-built humanoid platforms with their own funding, talent, and iteration cycles. And the leap from functional prototype to high-volume, reliable commercial product is not trivial; Tesla has already experienced precisely this challenge with the Cybercab.
Until Optimus has a revenue model, a production timeline, and a demonstrated cost advantage over competitors, it belongs in the “optionality” column — not the core thesis stack.
Thesis 5: SpaceX — No Longer Just a Wildcard
As of the time of this article, SpaceX going public is no longer speculative.
On May 20, 2026, Space Exploration Technologies Corp. filed a Form S-1 registration statement with the SEC — a confirmed, public IPO prospectus for SpaceX, the world’s leading commercial launch provider. The offering covers Class A common stock, to be listed on Nasdaq and Nasdaq Texas under the ticker SPCX. Joint book-runners include Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup, and J.P. Morgan, among others.
What the S-1 reveals:
The filing consolidates a significantly expanded corporate entity. SpaceX’s financial statements have been recast to include the historical results of X.AI Holdings Corp. — acquired by SpaceX effective February 2, 2026 — and X Holdings Corp. (the entity behind X, formerly Twitter), which was acquired by xAI effective March 28, 2025. The combined entity therefore encompasses SpaceX’s launch and satellite businesses, Starlink, xAI (including Grok), and X. A five-for-one stock split of Class A, B, and C shares was effected on May 4, 2026.
The share structure gives Elon Musk dominant control. Class B shares carry 10 votes per share against Class A’s one vote. Musk, as founder, CEO, CTO, and Chairman, will hold majority voting power post-IPO, and the company will operate as a “controlled company” under Nasdaq governance rules — meaning it can rely on exemptions from certain board independence requirements.
Why this matters for TSLA investors:
First of all, the SpaceX IPO sharpens the question of Musk’s bandwidth. He is simultaneously CEO of Tesla, CEO/CTO/Chairman of a newly public SpaceX that includes xAI and X, and still a key figure at The Boring Company. The governance concern raised in the risks section below is no longer hypothetical — it is acute.
Apart from that, several implications are worth tracking:
• Near-term (weeks/months): Mild valuation uplift from the SpaceX stake + possible sentiment-driven volatility or rotation pressure on TSLA.
• Medium-term: Risk that Musk’s bandwidth and investor excitement tilt toward SpaceX, making Tesla feel like the “legacy” play.
• Longer-term: Depends heavily on execution. Strong SpaceX performance could create positive halo effects and synergies; weak performance or Musk over-extension could weigh on both.
And then there are theories surrounding a potential Tesla-SpaceX merger or reverse merger:
Analysts such as Wedbush’s Dan Ives describing it as the “holy grail” that would combine Tesla’s robotics, robotaxis and autonomy with SpaceX’s Starlink, orbital infrastructure and AI compute into one Musk-led entity, with some suggesting SpaceX could use its public valuation as a benchmark for a later stock-for-stock “merger of equals.”
And arguing the opposite case, Chamath Palihapitiya and others continue to float a reverse merger of SpaceX into Tesla to consolidate Musk’s assets under one cap table and voting control structure, though the S-1 itself contains no merger plans and betting markets assign only modest odds (roughly 17–37% by end of 2027).
Tesla investors remain split on dilution risks versus massive long-term synergies. And until we see a formal announcement or definitive merger agreement, these remain in the realm of speculations.
Slowly, Then All at Once
Autonomous driving, when it is solved, will not happen incrementally across the market. The economic disruption — to ridesharing, to trucking, to insurance, to parking — will be a cliff-edge event, not a gradual slope.
The retail investor argument is essentially this: institutions will re-rate the moment the software crosses the threshold, and by the time they do, the stock will have already moved.
This is why retail investors cite Musk’s timeline failures not as disqualifying evidence but as evidence of cautious iteration. Two of the most widely reported missed promises are worth holding in full view:
- July 2019: Musk publicly stated Tesla would have “one million robotaxis on the road by the end of 2020.” As of mid-2026, Tesla has only just begun limited geofenced Cybercab pilot operations.
- December 2019: Musk promised FSD would be “feature complete” by end of 2019 and achieve Level 5 full autonomy in 2020. Neither milestone was met. As of the Q1 2026 earnings call, unsupervised FSD is slated for “probably Q4 2026.”
The retail bull interpretation: Musk over-promises chronologically but eventually delivers technologically. Cybercab production has started, FSD miles are accumulating, and the regulatory pathway is clearer than competitors’. Every year the timeline slips is another year of training data accumulation.
The counter-argument deserves equal weight: a pattern of material timeline misstatements from a CEO is a governance risk, not a feature. “He eventually delivers” is not language that belongs in a fund mandate. There is also a survivorship bias problem in the retail conviction argument — most investors who held speculative tech through 2021–2022 on the same “wait for the thesis to materialise” logic did not outperform. Conviction asymmetry is a real edge, but only when the underlying thesis proves out.
The Risks — Be Honest About These
1. Autonomy may not be solved as quickly as bulls believe
The gap between Level 2+ supervised and Level 4+ unsupervised operation is not incremental — it involves solving rare, edge-case scenarios that are underrepresented in training data precisely because they occur infrequently. Tesla’s supervised crash rate remains roughly 4x human performance. Waymo’s lidar + HD map approach may prove more reliable than Tesla’s camera-only system. These are not the same technical problem.
2. China risk
Tesla’s China sales are under structural pressure from domestic competitors and from the political dynamics between Washington and Beijing. Any escalation in trade tensions or regulatory action against US technology companies in China hits Tesla directly and with limited ability to hedge.
3. Regulatory risk on Cybercab
Tesla’s self-certification argument has not been stress-tested in commercial operation. A single high-profile incident — even in supervised mode — could trigger NHTSA action that halts deployment programs at the worst possible moment in the ramp curve.
4. Musk distraction and governance risk — now elevated
This risk has materially intensified since the SpaceX S-1 was filed. Musk is now simultaneously: CEO of Tesla; CEO, CTO, and Chairman of a newly public SpaceX entity that also encompasses xAI and X; and an ongoing presence at The Boring Company. The S-1 itself notes that SpaceX will operate as a “controlled company” under Nasdaq rules, allowing exemptions from standard board independence requirements. Retail investors in TSLA are now also, implicitly, exposed to the execution demands placed on a single person running four interconnected enterprises — with limited structural oversight on any of them.
5. Valuation risk
Multiple compression is a genuine threat if any of the above theses miss on schedule. At elevated multiples, even a fundamentally strong company can be a poor investment if growth disappoints. The forward P/E of 204x leaves very little room for narrative slippage.
The Bottom Line
The institutions aren’t fools. They can see the Cybercab production data, the FSD accumulation, the Megapack revenue, the Optimus demos, and the SpaceX IPO filing. They’re not ignoring any of it — they’re applying a risk-adjusted discount to a series of high-variance bets being made by a CEO whose attention is now formally, publicly, and structurally divided across multiple publicly accountable entities.
The retail investor’s edge — if it exists — is not information asymmetry. It’s conviction asymmetry: the ability to hold a position through short-term volatility on a long-term structural thesis, without the quarterly redemption pressure that forces institutional managers to mark to consensus. But conviction without clear-eyed risk assessment isn’t an edge — it’s exposure.
If you’re long TSLA, be precise about what you’re buying: not a car company, not a guaranteed autonomous fleet, but a portfolio of high-variance bets attached to an operator whose ambition is now distributed across more public enterprises than at any previous point in his career. Some of those bets will miss. If even one of the big ones hits — FSD at scale, Megapack at utility-grade infrastructure, Optimus at commercial deployment — the re-rating could be significant.
The question isn’t whether Tesla is extraordinary. It clearly is. The question is whether the current price adequately reflects the probability-weighted outcome of all five theses, discounted appropriately for a governance structure that is becoming harder to underwrite by the quarter.
That’s the bet you’re making.
Wall St. Down Under | Australia
Subscribe | wallstdownunder.com.au
Disclaimer: This newsletter is for informational and educational purposes only. It does not constitute financial advice. Wall St. Down Under is not a licensed financial adviser. Always do your own research and consider seeking advice from a qualified professional before making any investment decisions.